Spaulding Clinical Research, the US-based provider of clinical pharmacology and cardiac core-laboratory services, is joining the network of clinical trial sites that participate in clinicalRSVP’s Research Subject Verification Program.
According to the new partners, Spaulding Clinical is the first site in the Midwest to join clinicalRSVP’s North American network, which includes sites located along both US coasts.
clinicalRSVP provides participant registry services to prevent healthy volunteers from enrolling in concurrent or overlapping Phase I trials.
The company was chosen as Spaulding Clinical’s preferred provider of dual-enrolment protection services on account of its “expansive network, proven track record, ease of operational implementation, and regulatory compliance”, the latter said.
The addition of Spaulding Clinical to the network “represents a terrific advancement for clinicalRSVP and for those who sponsor and conduct Phase I clinical trials across North America”, commented clinicalRSVP president Darran Boyer.
